Cargando…

A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy

PURPOSE: To investigate planning time and number of optimizations in routine clinical lung cancer plans based on the plan quality improvements following each optimization. MATERIALS AND METHOD: We selected 40 patients with lung cancer who were treated with conventional fractionated radiotherapy (CFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Wenlong, Liu, Zhiqiang, Yan, Lingling, Han, Fei, Hu, Zhihui, Tian, Yuan, Cui, Weijie, Ren, Wenting, Guo, Chenlei, Miao, Junjie, Dai, Jianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324705/
https://www.ncbi.nlm.nih.gov/pubmed/32237271
http://dx.doi.org/10.1002/acm2.12863
_version_ 1783551996429598720
author Xia, Wenlong
Liu, Zhiqiang
Yan, Lingling
Han, Fei
Hu, Zhihui
Tian, Yuan
Cui, Weijie
Ren, Wenting
Guo, Chenlei
Miao, Junjie
Dai, Jianrong
author_facet Xia, Wenlong
Liu, Zhiqiang
Yan, Lingling
Han, Fei
Hu, Zhihui
Tian, Yuan
Cui, Weijie
Ren, Wenting
Guo, Chenlei
Miao, Junjie
Dai, Jianrong
author_sort Xia, Wenlong
collection PubMed
description PURPOSE: To investigate planning time and number of optimizations in routine clinical lung cancer plans based on the plan quality improvements following each optimization. MATERIALS AND METHOD: We selected 40 patients with lung cancer who were treated with conventional fractionated radiotherapy (CFRT). The 40 plans (divided into two groups with one or two target volumes) were completed by 9 planners using volumetric modulated arc therapy (VMAT). A planning strategy, including technique script for each group and a planning process for data collection, was introduced. The total planning time, number of optimizations, and dose–volume parameters of each plan were recorded and analyzed. A plan quality metric (PQM) was defined according to the clinical constraints. Statistical analysis of parameters of each plan following each optimization was performed for evaluating improvements in plan quality. RESULTS: According to the clinical plans generated by different planners, the median number of optimizations of each group was 4, and the median planning time was approximately 1 h (68.6 min and 62.0 min for plans with one or two target volumes, respectively). The dose deposited in organs at risk (OARs) gradually decreased, and the PQM values gradually improved following each optimization. The improvements were significant only between adjacent optimizations from the first optimization (Opt1) to the third optimization (Opt3). CONCLUSION: Increasing the number of optimizations was associated with significantly improved sparing of OARs with slight effects on the dose coverage and homogeneity of target volume. Generally, based on the designed planning strategy, there was no significant improvement of the plan quality for more than three optimizations.
format Online
Article
Text
id pubmed-7324705
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73247052020-07-01 A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy Xia, Wenlong Liu, Zhiqiang Yan, Lingling Han, Fei Hu, Zhihui Tian, Yuan Cui, Weijie Ren, Wenting Guo, Chenlei Miao, Junjie Dai, Jianrong J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To investigate planning time and number of optimizations in routine clinical lung cancer plans based on the plan quality improvements following each optimization. MATERIALS AND METHOD: We selected 40 patients with lung cancer who were treated with conventional fractionated radiotherapy (CFRT). The 40 plans (divided into two groups with one or two target volumes) were completed by 9 planners using volumetric modulated arc therapy (VMAT). A planning strategy, including technique script for each group and a planning process for data collection, was introduced. The total planning time, number of optimizations, and dose–volume parameters of each plan were recorded and analyzed. A plan quality metric (PQM) was defined according to the clinical constraints. Statistical analysis of parameters of each plan following each optimization was performed for evaluating improvements in plan quality. RESULTS: According to the clinical plans generated by different planners, the median number of optimizations of each group was 4, and the median planning time was approximately 1 h (68.6 min and 62.0 min for plans with one or two target volumes, respectively). The dose deposited in organs at risk (OARs) gradually decreased, and the PQM values gradually improved following each optimization. The improvements were significant only between adjacent optimizations from the first optimization (Opt1) to the third optimization (Opt3). CONCLUSION: Increasing the number of optimizations was associated with significantly improved sparing of OARs with slight effects on the dose coverage and homogeneity of target volume. Generally, based on the designed planning strategy, there was no significant improvement of the plan quality for more than three optimizations. John Wiley and Sons Inc. 2020-04-01 /pmc/articles/PMC7324705/ /pubmed/32237271 http://dx.doi.org/10.1002/acm2.12863 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Xia, Wenlong
Liu, Zhiqiang
Yan, Lingling
Han, Fei
Hu, Zhihui
Tian, Yuan
Cui, Weijie
Ren, Wenting
Guo, Chenlei
Miao, Junjie
Dai, Jianrong
A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
title A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
title_full A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
title_fullStr A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
title_full_unstemmed A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
title_short A longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
title_sort longitudinal evaluation of improvements in treatment plan quality for lung cancer with volumetric modulated arc therapy
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324705/
https://www.ncbi.nlm.nih.gov/pubmed/32237271
http://dx.doi.org/10.1002/acm2.12863
work_keys_str_mv AT xiawenlong alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT liuzhiqiang alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT yanlingling alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT hanfei alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT huzhihui alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT tianyuan alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT cuiweijie alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT renwenting alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT guochenlei alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT miaojunjie alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT daijianrong alongitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT xiawenlong longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT liuzhiqiang longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT yanlingling longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT hanfei longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT huzhihui longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT tianyuan longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT cuiweijie longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT renwenting longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT guochenlei longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT miaojunjie longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy
AT daijianrong longitudinalevaluationofimprovementsintreatmentplanqualityforlungcancerwithvolumetricmodulatedarctherapy